Rosuvastatin
- TRADE NAME: Crestor (AstraZeneca)
- INDICATIONS: Hypercholesterolemia, mixed dyslipidemia
- CLASS: HMG-CoA reductase inhibitor / statin
- HALF-LIFE: ~19 hours
Alcohol, Amiodarone, Antacids, Atazanavir, Ciprofibrate, Colchicine, Conivaptan, Coumarins, Cyclosporine, Daptomycin, Darunavir, Dronedarone, Elbasvir & Grazoprevir, Eltrombopag, Eluxadoline, Erythromycin, Ethinylestradiol, Fenofibrate, Fibrates, Fosamprenavir, Fusidic Acid, Gemfibrozil, Indinavir, Ledipasvir & Sofosbuvir, Letermovir, Lopinavir, Nelfinavir, Niacin, Niacinamide, Phenindione, Progestins, Protease inhibitors, Ritonavir, Safinamide, Saquinavir, Sofosbuvir/Velpatasvir/Voxilaprevir, Tafamidis meglumine, Tipranavir, Trabectedin, Vitamin K antagonists, Warfarin
PREGNANCY CATEGORY: X
Please login to see the rest of this drug profile
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of rosuvastatin in the Informa Healthcare journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 12/19/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric